UNIPHAR PLC EO -08
Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. The company provides sales, marketing, compliance, and distribution services to medical device manufacturers;… Read more
UNIPHAR PLC EO -08 (0NR) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, UNIPHAR PLC EO -08 (0NR) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
UNIPHAR PLC EO -08 - Net Assets Trend (None–None)
This chart illustrates how UNIPHAR PLC EO -08's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for UNIPHAR PLC EO -08 (None–None)
The table below shows the annual net assets of UNIPHAR PLC EO -08 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to UNIPHAR PLC EO -08's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
UNIPHAR PLC EO -08 Competitors by Market Cap
The table below lists competitors of UNIPHAR PLC EO -08 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Mercialys
PINK:MEIYF
|
$955.20 Million |
|
Chongqing Three Gorges Water Conservancy and Electric Power Co Ltd
SHG:600116
|
$955.67 Million |
|
InterRent Real Estate Investment Trust
PINK:IIPZF
|
$955.74 Million |
|
Shandong Dongyue Organosilicon Mat
SHE:300821
|
$955.84 Million |
|
Ninety One Group
PINK:NINTF
|
$954.35 Million |
|
Guodian Nanjing Automation Co Ltd
SHG:600268
|
$954.10 Million |
|
Shaanxi Lighte Optoelectronics Material Co. Ltd. A
SHG:688150
|
$953.57 Million |
|
Montnets Cloud Technology Group Co Ltd
SHE:002123
|
$953.24 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in UNIPHAR PLC EO -08's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares UNIPHAR PLC EO -08's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently UNIPHAR PLC EO -08 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares UNIPHAR PLC EO -08's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $1,192,244,105,699
- Average return on equity (ROE) among peers: -83.41%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| UNIPHAR PLC EO -08 (0NR) | €- | N/A | N/A | $954.96 Million |
| KIMIA FARMA -B- (HQP) | $5.89 Trillion | 5.13% | 1.93x | $78.59 Million |
| Asker Healthcare Group AB (I88) | $3.50 Billion | 10.28% | 2.75x | $1.37 Billion |
| Paragon Care Limited (PXS) | $18.21 Million | 5.96% | 0.48x | $52.86 Million |
| TELES Informationstechnologien AG (TLIK) | $379.23K | -446.97% | 3.69x | $801.14K |
| Sinopharm Group Co. Ltd (X2S) | $68.28 Billion | 8.55% | 2.45x | $3.27 Billion |